Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Author Correction: Introducing metal-sulfur active sites in metal-organic frameworks via post-synthetic modification for hydrogenation catalysis.
Journal: Nature chemistry
Published: September 23, 2025
Academic-Industrial Collaboration in Synthesis with Real-Time Impact in Medicinal Chemistry: Discovery of Cystic Fibrosis C2 Corrector ABBV-602.
Journal: ACS medicinal chemistry letters
Published: July 25, 2025
Introducing metal-sulfur active sites in metal-organic frameworks via post-synthetic modification for hydrogenation catalysis.
Journal: Nature chemistry
Published: October 29, 2024
Discovery of novel cyclopentane carboxylic acids as potent and selective inhibitors of NaV1.7.
Journal: Bioorganic & medicinal chemistry letters
Published: September 20, 2024
The contribution of NaV1.6 to the efficacy of voltage-gated sodium channel inhibitors in wild type and NaV1.6 gain-of-function (GOF) mouse seizure control.
Journal: British journal of pharmacology
Published: December 21, 2023
Identification of CNS-Penetrant Aryl Sulfonamides as Isoform-Selective NaV1.6 Inhibitors with Efficacy in Mouse Models of Epilepsy.
Journal: Journal of medicinal chemistry
Published: September 19, 2019
Chemical architecture and applications of nucleic acid derivatives containing 1,2,3-triazole functionalities synthesized via click chemistry.
Journal: Molecules (Basel, Switzerland)
Published: September 21, 2012
Gene-silencing properties of siRNAs that contain internal amide-bond linkages.
Journal: Bioorganic & medicinal chemistry letters
Published: July 26, 2012
Synthesis and properties of RNAs that contain a PNA-RNA dimer.
Journal: Nucleosides, nucleotides & nucleic acids
Published: April 14, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026